CNBC Investing Club

Eli Lilly CEO says latest results from obesity drug trial are the 'best-case scenario'

David Ricks, CEO, Eli Lilly
Scott Mlyn | CNBC

More In CNBC Investing Club Newsletter

CNBC Investing ClubNew analyst reports support our view of Constellation as a great defensive play
CNBC Investing ClubWall Street notes on Apple, Qualcomm highlight the long-term opportunities in those stocks
CNBC Investing ClubTuesday's market bounce allows us to raise some cash to buy in the next downturn